+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Organoids Services Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

  • PDF Icon

    Report

  • 136 Pages
  • August 2025
  • Region: Asia Pacific
  • The Insight Partners
  • ID: 6178425
Description Jump to:
The Asia Pacific organoids services market is projected to grow significantly, reaching approximately US$ 2.32 billion by 2031, up from US$ 515.83 million in 2024, reflecting a robust compound annual growth rate (CAGR) of 24.0% during the forecast period from 2024 to 2031.

Executive Summary and Market Analysis

The market is divided into several regions, including Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. The rapid growth in this region is driven by several factors, including the increasing adoption of organoids, government initiatives to promote awareness of human organoids, supportive regulatory frameworks for the development and commercialization of advanced organoid products, and a rise in funding for organoid research.

Market Segmentation Analysis

The Asia Pacific organoids services market can be segmented by type, application, and source:

  • By Type: The market includes segments such as intestine, liver, stomach, pancreas, lung, brain, kidney, and others. In 2024, the intestine segment is expected to dominate the market share.
  • By Application: The applications are categorized into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, among others. The developmental biology disease segment is anticipated to hold the largest market share in 2024.
  • By Source: The market is divided into pluripotent stem cells and organ-specific adult stem cells, with the pluripotent stem cells segment expected to lead in market share in 2024.

Market Outlook

The healthcare sector's advancements have led to increased demand for organoids globally, fostering new product developments, acquisitions, partnerships, and product launches. Recent notable developments in the market include:
  • June 2024: Molecular Devices, LLC opened a new facility in Cardiff, UK, designed for large-scale production of patient-derived organoids (PDOs) using innovative bioprocess technology.
  • May 2024: InSphero entered a partnership with Genome Biologics to commercialize a 3D Cardiac Organoid Platform, enhancing heart disease research capabilities.
  • January 2024: HUB Organoids launched IntegriGut Screen services, utilizing IBD patient-derived organoid monolayers to support the development of new IBD therapies.
  • July 2023: Molecular Devices expanded its custom organoid line service for high-throughput applications.
  • February 2023: A strategic collaboration between Molecular Devices and HUB Organoids aimed to advance 3D biology technologies to reduce drug attrition rates.
  • December 2022: Molecular Devices acquired Cellesce Ltd. to enhance PDO production capabilities for drug screening.
  • August 2021: STEMCELL Technologies partnered with HUB to provide tissue-derived organoids for preclinical testing.
  • May 2020: CELLINK collaborated with AstraZeneca to develop 3D bioprinted liver organoids for drug discovery.
  • February 2020: InnoSer and OrganoTherapeutics announced a collaboration to commercialize midbrain organoids for Parkinson's disease research.
These developments indicate a vibrant market landscape with numerous opportunities for growth in organoid services.

Country Insights

The Asia Pacific Organoids Services Market includes key countries such as Australia, China, India, Japan, South Korea, and others. China is expected to hold the largest market share in 2024, driven by the growing interest in personalized medicine, which fuels organoid research and development. Notable initiatives in China include a partnership between HUB and BGI-Qingdao to enhance personalized care and the introduction of a robot with a human brain organoid, showcasing advancements in organoid technology.

Company Profiles

Key players in the Asia Pacific organoids services market include CUSABIO TECHNOLOGY LLC, Cyprio, Eurofins Scientific SE, HUB Organoids B.V., InnoSer, InSphero, LABTOO, Molecular Devices, LLC, Oncodesign Services, and Sino Biological Inc. These companies are pursuing various strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific organoids services market.
  • Highlights key business priorities to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific organoids services market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific organoids services market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

Table of Contents

1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation
3.2.2 Macro-economic factor analysis
3.2.3 Developing base number
3.2.4 Data Triangulation
3.2.5 Country level data
4. Asia Pacific Organoids Services Market Landscape
4.1 PEST Analysis
5. Asia Pacific Organoids Services Market - Key Market Dynamics
5.1 Asia Pacific Organoids Services Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Demand for Innovative Drug Screening Services
5.2.2 Surge in Popularity of Personalized Drugs
5.3 Market Restraints
5.3.1 Dearth of Skilled Professionals
5.4 Market Opportunities
5.4.1 Increasing Key Developments
5.5 Future Trends
5.5.1 Integration of Artificial Intelligence
5.6 Impact of Drivers and Restraints
6. Asia Pacific Organoids Services Market - Analysis
6.1 Asia Pacific Organoids Services Market Revenue (US$ Million), 2021-2031
6.2 Asia Pacific Organoids Services Market Forecast Analysis
7. Asia Pacific Organoids Services Market Analysis - by Type
7.1 Intestine
7.1.1 Overview
7.1.2 Intestine: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Liver
7.2.1 Overview
7.2.2 Liver: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Stomach
7.3.1 Overview
7.3.2 Stomach: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Pancreas
7.4.1 Overview
7.4.2 Pancreas: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Lung
7.5.1 Overview
7.5.2 Lung: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Brain
7.6.1 Overview
7.6.2 Brain: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.7 Kidney
7.7.1 Overview
7.7.2 Kidney: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8. Asia Pacific Organoids Services Market Analysis - by Application
8.1 Developmental Biology Disease
8.1.1 Overview
8.1.2 Developmental Biology Disease: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Pathology of Infectious Disease
8.2.1 Overview
8.2.2 Pathology of Infectious Disease: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Regenerative Medicine
8.3.1 Overview
8.3.2 Regenerative Medicine: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Drug Toxicity and Efficacy Testing
8.4.1 Overview
8.4.2 Drug Toxicity and Efficacy Testing: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Drug Discovery and Personalized Medicine
8.5.1 Overview
8.5.2 Drug Discovery and Personalized Medicine: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
9. Asia Pacific Organoids Services Market Analysis - by Source
9.1 Pluripotent Stem Cells
9.1.1 Overview
9.1.2 Pluripotent Stem Cells: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Organ Specific Adult Stem Cell
9.2.1 Overview
9.2.2 Organ Specific Adult Stem Cell: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10. Asia Pacific Organoids Services Market - Country Analysis
10.1 Asia Pacific
10.1.1 Asia Pacific Organoids Services Market - Revenue and Forecast Analysis - by Country
10.1.1.1 Asia Pacific Organoids Services Market - Revenue and Forecast Analysis - by Country
10.1.1.2 Japan: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.1.1.2.1 Japan: Asia Pacific Organoids Services Market Share - by Type
10.1.1.2.2 Japan: Asia Pacific Organoids Services Market Share - by Application
10.1.1.2.3 Japan: Asia Pacific Organoids Services Market Share - by Source
10.1.1.3 China: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.1.1.3.1 China: Asia Pacific Organoids Services Market Share - by Type
10.1.1.3.2 China: Asia Pacific Organoids Services Market Share - by Application
10.1.1.3.3 China: Asia Pacific Organoids Services Market Share - by Source
10.1.1.4 India: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.1.1.4.1 India: Asia Pacific Organoids Services Market Share - by Type
10.1.1.4.2 India: Asia Pacific Organoids Services Market Share - by Application
10.1.1.4.3 India: Asia Pacific Organoids Services Market Share - by Source
10.1.1.5 South Korea: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.1.1.5.1 South Korea: Asia Pacific Organoids Services Market Share - by Type
10.1.1.5.2 South Korea: Asia Pacific Organoids Services Market Share - by Application
10.1.1.5.3 South Korea: Asia Pacific Organoids Services Market Share - by Source
10.1.1.6 Australia: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.1.1.6.1 Australia: Asia Pacific Organoids Services Market Share - by Type
10.1.1.6.2 Australia: Asia Pacific Organoids Services Market Share - by Application
10.1.1.6.3 Australia: Asia Pacific Organoids Services Market Share - by Source
10.1.1.7 Rest of Asia Pacific: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.1.1.7.1 Rest of Asia Pacific: Asia Pacific Organoids Services Market Share - by Type
10.1.1.7.2 Rest of Asia Pacific: Asia Pacific Organoids Services Market Share - by Application
10.1.1.7.3 Rest of Asia Pacific: Asia Pacific Organoids Services Market Share - by Source
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in Organoids Services Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Sino Biological Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Eurofins Scientific SE
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Molecular Devices, LLC.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 InSphero
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Cyprio
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 InnoSer
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 LABTOO
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 CUSABIO TECHNOLOGY LLC
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Oncodesign Services
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 HUB Organoids B.V. (Hubrecht Organoid Technology)
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms
List of Tables
Table 1. Asia Pacific Organoids Services Market Segmentation
Table 2. Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Table 3. Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Type
Table 4. Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
Table 5. Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Source
Table 6. Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
Table 7. Japan: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 8. Japan: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 9. Japan: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
Table 10. China: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 11. China: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 12. China: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
Table 13. India: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 14. India: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 15. India: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
Table 16. South Korea: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 17. South Korea: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 18. South Korea: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
Table 19. Australia: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 20. Australia: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 21. Australia: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
Table 22. Rest of Asia Pacific: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 23. Rest of Asia Pacific: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 24. Rest of Asia Pacific: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
Table 25. Recent Organic Growth Strategies in Organoids Services Market
Table 26. Recent Inorganic Growth Strategies in the Organoids Services Market
Table 27. Glossary of Terms, Organoids Services Market
List of Figures
Figure 1. Asia Pacific Organoids Services Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Organoids Services Market Revenue (US$ Million), 2021-2031
Figure 5. Asia Pacific Organoids Services Market Share (%) - by Type (2023 and 2031)
Figure 6. Intestine: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 7. Liver: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 8. Stomach: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 9. Pancreas: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 10. Lung: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 11. Brain: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 12. Kidney: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 13. Others: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 14. Asia Pacific Organoids Services Market Share (%) - by Application (2023 and 2031)
Figure 15. Developmental Biology Disease: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 16. Pathology of Infectious Disease: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 17. Regenerative Medicine: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 18. Drug Toxicity and Efficacy Testing: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 19. Drug Discovery and Personalized Medicine: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 20. Others: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 21. Asia Pacific Organoids Services Market Share (%) - by Source (2023 and 2031)
Figure 22. Pluripotent Stem Cells: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 23. Organ Specific Adult Stem Cell: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 24. Asia Pacific Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 25. Japan: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 26. China: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 27. India: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 28. South Korea: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 29. Australia: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 30. Rest of Asia Pacific: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 31. Growth Strategies in Organoids Services Market

Companies Mentioned

Some of the leading companies in the Asia Pacific Organoids Services Market include:

  • CUSABIO TECHNOLOGY LLC
  • Cyprio
  • Eurofins Scientific SE
  • HUB Organoids B.V. (Hubrecht Organoid Technology)
  • InnoSer
  • InSphero
  • LABTOO
  • Molecular Devices, LLC.
  • Oncodesign Services
  • Sino Biological Inc.

Related Topics

Related Reports

Asia Pacific Organoids Services Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis - Product Image

Asia Pacific Organoids Services Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

  • Report
  • 136 Pages
  • Asia Pacific
From
Organoids Services Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend and Growth Opportunity Analysis Report Coverage: By Type, Application, Source and Geography - Product Image

Organoids Services Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend and Growth Opportunity Analysis Report Coverage: By Type, Application, Source and Geography

  • Report
  • 168 Pages
  • Global
From
Organoids Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, Source, Offering, Method, and Geography - Product Image

Organoids Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, Source, Offering, Method, and Geography

  • Report
  • 297 Pages
  • Global
From
Europe Organoids Services Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis - Product Image

Europe Organoids Services Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

  • Report
  • 136 Pages
  • Europe
From
Europe Organoids Services Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis - Product Image

Europe Organoids Services Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

  • Report
  • 136 Pages
  • Europe
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.